Versant Capital Management
KRRO icon

Versant Capital Management’s Korro Bio KRRO Stock Holding History

Versant Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.83K Sell
487
-52
-10% -$640 ﹤0.01% 2459
2026
Q2 		$7.1K Sell
539
-152
-22% -$1.89K ﹤0.01% 2346
2026
Q1 		$7.82K Buy
+691
New +$7.61K ﹤0.01% 2235
2025
Q4 		– Sell
-271
Closed -$13K – 2698
2025
Q3 		$13K Sell
271
-11
-4% -$244 ﹤0.01% 1818
2025
Q2 		$3.52K Buy
+282
New +$4.06K ﹤0.01% 2272

Other funds holding KRRO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
KCM
Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Versant Capital Management's KRRO Position: Q3 2026 in Review

Versant Capital Management reduced its Korro Bio (KRRO) stake by 9.6% in Q3 2026, selling an estimated $640 and leaving 487 shares worth $4.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2459.

Versant Capital Management first reported a position in KRRO in Q2 2025 and has held it in 5 quarters since. The position peaked at $13K in Q3 2025. 68 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • Versant Capital Management held 487 shares of Korro Bio worth $4.83K as of Q3 2026.
  • Versant Capital Management sold 52 Korro Bio shares in Q3 2026, an estimated $640.
  • Korro Bio made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2459 holding.
  • Versant Capital Management first reported a position in Korro Bio in Q2 2025 and has held it in 5 quarters since.
  • Versant Capital Management's Korro Bio position peaked at $13K in Q3 2025.
  • 68 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.